Snapshot from Jun 28, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Riad Sherif
Person

Riad Sherif

Tracked across 1 events · 7 articles · First seen May 29, 2026 · Last active Jun 11, 2026

Sentiment
60
Attention
4
Events
1
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 60
Tech
Oculis Presents Privosegtor Optic Neuritis Data
Oculis announced an upcoming presentation at Clinical Trials at the Summit 2026, where its CEO, Riad Sherif, will highlight the development journey of Privosegtor. Privosegtor is a novel peptoid small molecule with the potential to…
Impact: Riad Sherif, as CEO of Oculis, is the presenter of the Privosegtor program, emphasizing the company's strategic direction and the potential of the drug.
Jun 11, 2026 · 7 articles
Key Actions (2)
95 Riad Sherif presented programOculis Presents...
80 Riad Sherif claimed product worksOculis OCS-01 trial...
Relationships (4)
Oculis ↔ Riad Sherif
Oculis ↔ Riad Sherif
United States — Food and Drug Administration ↔ Riad Sherif
United States — Food and Drug Administration ↔ Riad Sherif
NEWSDESK
Track Riad Sherif live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.